Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Transplant Procedures
4.2.2 Technological Advacements in Transplant Diagnostics
4.2.3 Government and Private Collaboration into Funding Research of Target Diseases
4.3 Market Restraints
4.3.1 High Cost of Transplant
4.3.2 Insurance and Reimbursement Policies
4.3.3 Social and Ethical Issues Related to Organ Transplant
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Molecular
5.1.1.1 PCR based Molecular Assays
5.1.1.2 Sequencing Based Molecular Assays
5.1.2 Non-Molecular
5.2 By Product
5.2.1 Instrument
5.2.2 Reagent
5.2.3 Software
5.3 By Transplant Type
5.3.1 Solid Organ Transplant
5.3.2 Stem Cell Transplant
5.3.3 Soft Tissue Transplant
5.4 By Application
5.4.1 Diagnostic Applications
5.4.2 Research Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 France
5.5.2.2 Germany
5.5.2.3 United Kingdom
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 Biom?rieux SA
6.1.4 Bio-Rad Laboratories Inc
6.1.5 CareDx
6.1.6 F. Hoffman-La Roche Limited
6.1.7 Hologic
6.1.8 Illumina
6.1.9 Qiagen
6.1.10 Thermo Fisher Scientific, Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS